Presentation ACC 2012 Renal Sympathetic Denervation for Treatment of Resistant Hypertension: One-Year Results from the Symplicity HTN-2 Randomized Controlled Trial Presenter: Murray Esler March 25, 2012
Presentation ACC 2012 Effect of Transendocardial Delivery of Autologous Bone Marrow Mononuclear Cells on Functional Capacity, Left Ventricular Function, and Perfusion in Chronic Ischemic Heart Failure: The FOCUS-CCTRN Trial Presenter: Emerson C. Perin March 25, 2012
Presentation ACC 2012 A Double Blind Randomized Study to Evaluate the Efficacy of Bindarit in Preventing Coronary Stent Restenosis Presenter: Antonio Colombo March 25, 2012
Presentation ACC 2012 2 Year Clinical Outcomes from the Pivotal RESOLUTE US Study Presenter: Laura Mauri March 25, 2012
Presentation ACC 2012 Biodegradable Polymer Drug-Eluting Stents Versus Durable Polymer Sirolimus-Eluting Stents in Patients Undergoing Percutaneous Coronary Intervention Presenter: Robert A. Byrne March 24, 2012
Presentation Balloon-pump assisted Coronary Intervention Study (BCIS-1): Long term Mortality Data Presenter: 130910|Divaka Perera March 24, 2012
Presentation ACC 2012 First Pharmacogenomic Analysis Using Whole Exome Sequencing to Identify Novel Genetic Determinants of Clopidogrel Presenter: Matthew Price March 24, 2012
Presentation ACC 2012 Adjunctive Cilostazol Versus Double Dose Clopidogrel After PCI with Drug Eluting Stent: The HOST-ASSURE Randomized Trial Presenter: Hyo-Soo Kim March 24, 2012
Presentation ACC 2012 RESET Study: Pharmacodynamic Effects of Switching Therapy in PCI Patients with High on Treatment Platelet Reactivity and Genotype Variation: High Clopidogrel Dose versus Prasugrel Presenter: Gennaro Sardella March 24, 2012
Presentation ACC 2012 Economic Impact of Transradial Percutaneous Coronary Intervention Presenter: David Safley March 24, 2012